Skip to contentSkip to Braille Studio

Library / Laws / 119th Congress / House Bills / H.R. 7693

H.R. 7693

To mitigate the effects of the COVID–19 pandemic on incentives under the Federal Food, Drug, and Cosmetic Act for the development of orphan drugs, and for other purposes.

Print stageDateSize⠃
Introduced in House2026-02-254.5K⠃⠗⠋